Price range: £46.00 through £71.00
For research use only — Not for human or animal use
CJC-1295 + Ipamorelin Blend (5mg/5mg) is a research peptide combination designed for laboratory and in vitro use. It combines two well-studied compounds from GHRH analogues and growth hormone secretagogues. This makes it a common choice for studies on endocrine signalling.
This blend explores how the body regulates growth hormone (GH). Controlled studies reference CJC-1295 for its role in increasing growth hormone and IGF-1 levels over time. By contrast, Ipamorelin selectively targets receptors that signal the pituitary gland to release GH.
Together, CJC-1295 and ipamorelin are used to study growth hormone production and levels. They also help researchers learn how the body naturally regulates these processes.
Researchers commonly use subcutaneous injection in research settings to study how these compounds behave. This includes examining absorption, assessing the injection-site response, and analyzing how signaling pathways activate and remain active. These models help build a clearer picture of natural growth hormone regulation and peptide interaction.
There’s also wider scientific interest in how growth hormone affects muscle growth, lean muscle mass, and body composition. It may also relate to fat loss, sleep quality, and anti-ageing.
That said, evidence for the combined blend in these areas is still limited and more search is needed to explore the benefits.
Each vial contains a balanced 5mg/5mg formulation, and we produce it to high purity standards. Batch testing supports consistency and reproducibility across experimental work.
For research purposes only. Not for human or veterinary use.
Disclaimer: This product is intended for laboratory research use only. It is not for human or animal consumption. It is not intended for diagnostic, therapeutic, or clinical use.
Discount Applied Successfully!
Your savings have been added to the cart.
